Dear Friends,

It’s been over 30 years since our friend, founder and inspiration, Sharon Monsky, challenged us to achieve one overarching goal: find a cure for scleroderma and then close our doors. Today we remain as dedicated as ever to that goal, and the SRF has been able to leverage its reputation for research leadership by bringing world-class scientific talent to the complex problem of scleroderma.

This effort has made  significant impact on translational and clinical issues that directly affect the patient community. Our most recent Annual Report details the progress of our funded research programs and the incredible commitment of our scleroderma community.  It’s because of your contributions that we have arrived where we are today, and are able to continue to move forward, onward, and upward.

Sincerely,

Luke Evnin, PhD.
Chairman